Harmony Biosciences Holdings, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US4131971040
USD
36.76
0.85 (2.37%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
239.46
200.49
184.73
201.27
186.04
172.81
154.62
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
239.46
200.49
184.73
201.27
186.04
172.81
154.62
Raw Material Cost
65.61
44.11
37.95
60.37
48.74
38.10
33.45
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.62
3.65
3.84
4.21
4.35
4.40
4.54
Selling and Distribution Expenses
53.40
58.04
55.99
50.50
50.20
49.77
46.95
Other Expenses
5.13
4.65
3.07
3.05
2.10
5.92
1.77
Total Expenditure (Excl Depreciation)
173.97
152.31
128.49
145.54
124.33
151.46
102.58
Operating Profit (PBDIT) excl Other Income
65.5
48.2
56.2
55.7
61.7
21.400000000000002
52
Other Income
5.62
5.10
4.77
4.64
4.81
4.74
4.29
Operating Profit (PBDIT)
77.08
59.25
66.98
66.33
72.49
32.15
62.44
Interest
3.62
3.65
3.84
4.21
4.35
4.40
4.54
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
173.84
156.38
146.78
140.90
137.30
134.71
121.17
Depreciation
5.97
5.97
5.97
5.97
5.97
6.05
6.12
Profit Before Tax
67.49
49.64
57.18
56.16
62.17
21.69
51.78
Tax
16.62
9.86
11.62
6.68
16.08
10.10
13.45
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
50.87
39.78
45.56
49.48
46.09
11.59
38.33
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
50.87
39.78
45.56
49.48
46.09
11.59
38.33
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
50.87
39.78
45.56
49.48
46.09
11.59
38.33
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
835.12
773.08
720.52
659.15
596.80
538.58
515.39
Earnings per share (EPS)
0.87
0.68
0.78
0.85
0.79
0.2
0.67
Diluted Earnings per share
0.87
0.68
0.78
0.85
0.79
0.2
0.67
Operating Profit Margin (Excl OI)
27.35%
24.03%
30.45%
27.69%
33.17%
12.36%
33.65%
Gross Profit Margin
30.68%
27.73%
34.18%
30.87%
36.63%
16.06%
37.45%
PAT Margin
21.24%
19.84%
24.66%
24.58%
24.78%
6.71%
24.79%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is 28.76% vs 16.03% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is 10.41% vs 19.74% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 5.61% vs -4.11% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is -16.28% vs -38.57% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024

Compare Quarterly Results Of Harmony Biosciences Holdings, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
239.46
0.00
239.46
Other Operating Income
0.00
0.00
0.00
Total Operating income
239.46
0.00
239.46
Raw Material Cost
65.61
0.63
64.98
10,314.29%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
36.10
-36.10
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
3.62
0.00
3.62
Selling and Distribution Expenses
53.40
19.24
34.16
177.55%
Other Expenses
5.13
3.83
1.30
33.94%
Total Expenditure (Excl Depreciation)
173.97
94.23
79.74
84.62%
Operating Profit (PBDIT) excl Other Income
65.49
-94.23
159.72
169.50%
Other Income
5.62
8.90
-3.28
-36.85%
Operating Profit (PBDIT)
77.08
-84.70
161.78
191.00%
Interest
3.62
0.00
3.62
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
173.84
-0.63
174.47
27,693.65%
Depreciation
5.97
0.63
5.34
847.62%
Profit Before Tax
67.49
-85.33
152.82
179.09%
Tax
16.62
-0.63
17.25
2,738.10%
Provisions and contingencies
0
0
0.00
Profit After Tax
50.87
-84.71
135.58
160.05%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
50.87
-84.71
135.58
160.05%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
50.87
-84.71
135.58
160.05%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
835.12
633.98
201.14
31.73%
Earnings per share (EPS)
0.87
-1.07
1.94
181.31%
Diluted Earnings per share
0.87
-1.07
1.94
181.31%
Operating Profit Margin (Excl OI)
27.35%
0.00%
0.00
27.35%
Gross Profit Margin
30.68%
0.00%
0.00
30.68%
PAT Margin
21.24%
0.00%
0.00
21.24%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 23.95 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 19.45% vs 8.55% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 28.76% vs 16.03% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 5.09 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 27.89% vs -12.72% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 10.41% vs 19.74% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.15 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 32.16% vs -13.02% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 5.61% vs -4.11% in Sep 2024

Quarterly - Interest
Interest 0.36 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 0.00% vs -5.26% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -16.28% vs -38.57% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 27.35%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024